Axon Enterprise, Inc. (NASDAQ:AXON) Stock Position Decreased by Zevenbergen Capital Investments LLC

Zevenbergen Capital Investments LLC decreased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 423,239 shares of the biotechnology company’s stock after selling 61,819 shares during the quarter. Axon Enterprise accounts for about 5.1% of Zevenbergen Capital Investments LLC’s holdings, making the stock its 5th biggest position. Zevenbergen Capital Investments LLC’s holdings in Axon Enterprise were worth $251,539,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of AXON. Groupama Asset Managment bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA bought a new stake in shares of Axon Enterprise in the 3rd quarter worth $120,553,000. Vanguard Group Inc. raised its stake in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth $78,414,000. Finally, Westfield Capital Management Co. LP lifted its holdings in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Stock Performance

Shares of AXON opened at $560.00 on Monday. The business has a 50-day simple moving average of $591.90 and a two-hundred day simple moving average of $543.57. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The stock has a market cap of $42.91 billion, a price-to-earnings ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.